Cargando…

Continuous Production of Galacto-Oligosaccharides by an Enzyme Membrane Reactor Utilizing Free Enzymes

Galacto-oligosaccharides (GOS) are prebiotic compounds widely used for their health-promoting effects. Conventionally, GOS is produced by the enzymatic conversion of lactose in stirred tank reactors (STR). The high operational costs associated with enzyme inactivation and removal might be reduced by...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Teng, Pázmándi, Melinda, Galambos, Ildikó, Kovács, Zoltán
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560224/
https://www.ncbi.nlm.nih.gov/pubmed/32867283
http://dx.doi.org/10.3390/membranes10090203
_version_ 1783595038187454464
author Cao, Teng
Pázmándi, Melinda
Galambos, Ildikó
Kovács, Zoltán
author_facet Cao, Teng
Pázmándi, Melinda
Galambos, Ildikó
Kovács, Zoltán
author_sort Cao, Teng
collection PubMed
description Galacto-oligosaccharides (GOS) are prebiotic compounds widely used for their health-promoting effects. Conventionally, GOS is produced by the enzymatic conversion of lactose in stirred tank reactors (STR). The high operational costs associated with enzyme inactivation and removal might be reduced by the application of enzyme membrane reactors (EMR). In this study, we aimed to assess the potential of continuous GOS production by EMR using soluble Biolacta N5, a Bacillus circulans-derived commercial enzyme preparation. The steady-state performance of the EMR equipped with an ultrafiltration module was investigated as function of residence time (1.1–2.8 h) and enzyme load (17–190 U·g(−1)) under fixed operational settings of temperature (50 °C), pH (6.0), lactose feed concentration (300 g·kg(−1)), and recirculation flow-rate (0.18 m(3)·h(−1)). Results indicate that the yield of oligosaccharides with higher degree of polymerization (DP3-6) in STR (approx. 38% on total carbohydrate basis) exceeds that measured in EMR (ranging from 24% to 33%). However, a stable catalytic performance without a significant deterioration in product quality was observed when operating the EMR for an extended period of time (>120 h). Approx. 1.4 kg of DP3-6 was produced per one gram of crude enzyme preparation over the long-term campaigns, indicating that EMR efficiently recovers enzyme activity.
format Online
Article
Text
id pubmed-7560224
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-75602242020-10-22 Continuous Production of Galacto-Oligosaccharides by an Enzyme Membrane Reactor Utilizing Free Enzymes Cao, Teng Pázmándi, Melinda Galambos, Ildikó Kovács, Zoltán Membranes (Basel) Article Galacto-oligosaccharides (GOS) are prebiotic compounds widely used for their health-promoting effects. Conventionally, GOS is produced by the enzymatic conversion of lactose in stirred tank reactors (STR). The high operational costs associated with enzyme inactivation and removal might be reduced by the application of enzyme membrane reactors (EMR). In this study, we aimed to assess the potential of continuous GOS production by EMR using soluble Biolacta N5, a Bacillus circulans-derived commercial enzyme preparation. The steady-state performance of the EMR equipped with an ultrafiltration module was investigated as function of residence time (1.1–2.8 h) and enzyme load (17–190 U·g(−1)) under fixed operational settings of temperature (50 °C), pH (6.0), lactose feed concentration (300 g·kg(−1)), and recirculation flow-rate (0.18 m(3)·h(−1)). Results indicate that the yield of oligosaccharides with higher degree of polymerization (DP3-6) in STR (approx. 38% on total carbohydrate basis) exceeds that measured in EMR (ranging from 24% to 33%). However, a stable catalytic performance without a significant deterioration in product quality was observed when operating the EMR for an extended period of time (>120 h). Approx. 1.4 kg of DP3-6 was produced per one gram of crude enzyme preparation over the long-term campaigns, indicating that EMR efficiently recovers enzyme activity. MDPI 2020-08-27 /pmc/articles/PMC7560224/ /pubmed/32867283 http://dx.doi.org/10.3390/membranes10090203 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Cao, Teng
Pázmándi, Melinda
Galambos, Ildikó
Kovács, Zoltán
Continuous Production of Galacto-Oligosaccharides by an Enzyme Membrane Reactor Utilizing Free Enzymes
title Continuous Production of Galacto-Oligosaccharides by an Enzyme Membrane Reactor Utilizing Free Enzymes
title_full Continuous Production of Galacto-Oligosaccharides by an Enzyme Membrane Reactor Utilizing Free Enzymes
title_fullStr Continuous Production of Galacto-Oligosaccharides by an Enzyme Membrane Reactor Utilizing Free Enzymes
title_full_unstemmed Continuous Production of Galacto-Oligosaccharides by an Enzyme Membrane Reactor Utilizing Free Enzymes
title_short Continuous Production of Galacto-Oligosaccharides by an Enzyme Membrane Reactor Utilizing Free Enzymes
title_sort continuous production of galacto-oligosaccharides by an enzyme membrane reactor utilizing free enzymes
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7560224/
https://www.ncbi.nlm.nih.gov/pubmed/32867283
http://dx.doi.org/10.3390/membranes10090203
work_keys_str_mv AT caoteng continuousproductionofgalactooligosaccharidesbyanenzymemembranereactorutilizingfreeenzymes
AT pazmandimelinda continuousproductionofgalactooligosaccharidesbyanenzymemembranereactorutilizingfreeenzymes
AT galambosildiko continuousproductionofgalactooligosaccharidesbyanenzymemembranereactorutilizingfreeenzymes
AT kovacszoltan continuousproductionofgalactooligosaccharidesbyanenzymemembranereactorutilizingfreeenzymes